M Ventures

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.

BiotechHealthtechWaltham, US

Rene Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Paul Clancy(Director)Daniel Curran(Director)Nancy Hong(Director)

Co-investorsBain Capital Life SciencesBay City CapitalF-Prime CapitalMRL Ventures FundRA CapitalRiverVest Venture Partners+4 more

Anjuna develops software for secure data sharing and confidential computing in cloud and AI environments.

AI & Machine LearningCloud ComputingCybersecurityDeep TechEnterprise SoftwareSan Francisco, US

Ayal Yogev(Founder/CEO)inSteve WeisYan M.(Founder)inYan Michalevsky(Founder)in

Co-investorsInsight PartnersSINEWAVE VENTURESAlpha Intelligence CapitalDCVC (Data Collective)Dorm RoomFounder Collective+3 more

Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech.

BiotechDeep TechMedical DevicesCulver City, US

James Heath(Director)Leroy Hood(Director)Andreas Jurgeit(Director)Heather Agnew(Executive Officer)Albert Luderer(Executive Officer, Director)Darren Cai(Director)

Co-investorsLegend CapitalAsset Management Company

Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)Terry Lo(Director)Seth Benson(Executive Officer)Simona Levi(Executive Officer)

Co-investorsARCH Venture PartnersNorthpond VenturesNovalis LifeSciences

Abselion develops measurement tools and a platform combining hardware, purpose-built assay formats, and software for biological measurements such as protein quantification.

BiotechDeep TechHardwareMedical DevicesCambridge, GB

Dr Ruizhi Wang(CEO)

Co-investorsCambridge Angels group

Actithera develops next-generation radioligand therapies that combine diagnostic imaging and targeted radiation therapy to treat cancer with improved efficacy and reduced side effects.

AI & Machine LearningBiotechHealthtechMedical Devices

Darshan Dalal(Chief Medical Officer)

Co-investorsHadean VenturesSofinnova Partners4BIO CapitalBioqube Ventures

Akili Interactive develops digital medicine delivered through video game experiences, combining neuroscience with interactive technology as a therapeutic treatment.

Digital HealthGamingHealthtech

Co-investorsDG Daiwa VenturesEvidity Health CapitalJAZZ Venture PartnersMachina VenturesWalnut Venture Associates

Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsAlpana VenturesEisai Innovation, Inc.Hikma VenturesPolytech Ecosystem VenturesVI PartnersWhitecap Venture Partners

Co-investors5AM Ventures

Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable.

BiotechHealthtechLeiden, NL

Birgit Zech(CEO)

Co-investorsTaiho Ventures, LLCBioqube VenturesInkef

Co-investorsNovartis Venture FundRA Capital

Artios develops DNA Damage Response (DDR)-based therapeutics for hard-to-treat solid tumors, including small-molecule inhibitors targeting ATR (alnodesertib) and DNA polymerase theta (ART6043).

BiotechHealthtech

Co-investorsAndera PartnersNovartis Venture FundPfizer Venture InvestmentsRA CapitalSofinnova PartnersSV Health Investors

Co-investorsKurma PartnersSofinnova PartnersSR One Capital Management

Developing The Benchtop Cell Factory, an end-to-end platform for Cell and Gene Therapy manufacturing using microfluidic technology.

Co-investorsAdBio partners

Co-investorsAdBio partners

beeOLED develops blue OLED emitters based on rare-earth (lanthanide) metal complexes, such as cerium or europium, stabilized with organic ligands and made vacuum-vaporizable for OLED display manufacturing.

Deep TechHardwareNew Materials

Dr. Carsten RotheDr. Volodymyr Senkovskyy

Co-investorsInnovation Industries

Biolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device.

Digital HealthHardwareMedical Devices

Jared Tangney(Founder)inRich Yangin

Co-investorsAble PartnersAlpha Wave GlobalAphelion CapitalAverin CapitalBOLD LongevityHikma Ventures+2 more

Co-investorsFountain Healthcare Partners

The page describes Photonic Fabric, an optical interconnect technology platform for the scale-up interconnect market that enables high-bandwidth, power-efficient links for AI data center infrastructure.

AI & Machine LearningDeep TechSector AgnosticSemiconductorsSanta Clara, US

Preetinder Virk(Chief Operating Officer)David Lazovsky(President and Chief Executive Officer)Kelyn Brannon(Chief Financial Officer)Philip Winterbottom(Chief Technology Officer)

BoardLip-Bu Tan(Director)Alonso Galvan(Director)

Co-investorsFitz Gate VenturesIAG Capital PartnersKoch Disruptive TechnologiesSamsung Catalyst FundThe Engine VenturesTyche Partners+2 more

CellFE develops a cell engineering system that transfects cells with genetic payloads through a gentle, rapid process designed for research and therapeutic cell engineering applications.

BiotechDeep TechHardwareMedical Devices

Co-investorsCota CapitalDynamk CapitalGreatPoint VenturesEmbark VenturesKhosla Ventures

ChemPower develops an abrasive-free chemical mechanical planarization (CMP) technology and materials for advanced semiconductor chip manufacturing.

Advanced ManufacturingCleantechNew MaterialsSemiconductorsBeaverton, US

Sudhanshu Misra(CEO)SV Babu(CTO)SUDHANSHU MISRA(Executive Officer, Director)

BoardSCOTT SHAW(Director)inOWEN LOZMAN(Director)JESSICA FREYER(Director)in

Co-investorsFoothill VenturesIntel CapitalPangaea Ventures Us Inc.Portland Seed FundRhapsody Venture PartnersTEL Venture Capital, Inc.+2 more

Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition.

AI & Machine LearningBiotechDeep TechCambridge, US

Jared Kehe(Executive Officer, Director)Cheri Ackerman(Executive Officer, Director)Bernardo Cervantes(Executive Officer, Director)inVera Schroeder(Director)

BoardSarah Luppino(Director)in

Co-investorsExcelestar VenturesGolden SeedsHorizons VenturesISVMassVenturesAxial VC

Corvic offers an enterprise AI platform that wraps frontier models with grounded playbooks, multi-agent workflows, persistent memory, and secure data handling to process structured and unstructured data at scale.

AI & Machine LearningData & InfrastructureEnterprise Software

Gurbinder Gill(Founder)in

Co-investorsFoothill VenturesLam CapitalSprout OakBosch VenturesK2 Access FundLDV Partners+1 more

Disco Pharmaceuticals develops cancer therapies using a cell surfaceome discovery technology to identify new molecular targets.

BiotechHealthtech

DNA Script develops enzymatic DNA synthesis technology, offered through its SYNTAX platform, that lets labs produce high-quality ssDNA oligos in-house and overnight.

BiotechDeep TechHardwareParis, FR

Thomas Ybert(Founder)in

Co-investorsCoatue ManagementKurma Partners

Electroninks develops and manufactures metal complex inks for semiconductor packaging, consumer electronics, and medical device manufacturing, offering improved conductivity and sustainability compared to traditional metallized inks.

Advanced ManufacturingHardwareNew MaterialsSemiconductorsAustin, US

Co-investorsBandgap VenturesIn-Q-Tel

Co-investorsPfizer Venture InvestmentsRA Capital

Co-investorsSEED Capital Denmark

FMC (Ferroelectric Memory Company) develops ferroelectric-based persistent memory technologies, including DRAM+ and 3D CACHE+, aimed at AI scale-out and critical infrastructure.

Deep TechHardwareSemiconductorsDresden, DE

Co-investorsBosch VenturesDeepTech & Climate FondsRobert Bosch Venture CapitalTEL Venture Capital, Inc.HV Capitalimec.xpand+3 more

Co-investorsInnovestor VenturesSunstone Capital

Formo uses precision fermentation to produce bio-identical milk proteins, such as its Formo Casein, that replicate the functionality, texture, and taste of dairy without animals.

BiotechClimate TechFoodTech

Co-investorsFoodLabsGood Seed VenturesGrazia Equity GmbHGrey Silo VenturesLOWERCARBONLowercarbon Capital+4 more

FoRx Therapeutics is a biotechnology company focused on oncology drug discovery and clinical development, targeting the DNA Damage Response (DDR) network with small molecule inhibitors.

BiotechDeep TechHealthtechBasel, CH

Tarig Bashir(Chief Executive Officer (CEO))Jens Würthner(Chief Medical Officer (CMO))Frank Zenke(Chief Scientific Officer (CSO))

Co-investorsNovartis Venture FundPfizer Venture Investments

Future Fertility develops an artificial intelligence tool to assess egg quality for fertility treatment using machine learning analysis of oocyte health.

AI & Machine LearningBiotechDigital HealthFemTechHealthtech

Rene Bharti(Co-founder)Dr. Dan Nayot(Co-founder)

Co-investorsWhitecap Venture PartnersGaingelsSandpiper Ventures

Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.

BiotechMedical Devices

Jennifer Jarrett(Chief Executive Officer & Board Director)Sherwin Sattarzadeh(Chief Operating Officer)Becker Hewes(Chief Medical Officer)Garrett Winslow(General Counsel)Jim Baker(Chief Corporate Affairs Officer)Brian Burkavage(Senior Vice President, Finance)

Co-investorsEIR VenturesHadean VenturesSEED Capital DenmarkSunstone CapitalYsios CapitalMaverick Ventures+1 more

Gamelynx develops cross-platform competitive games designed to be easy for audiences to watch.

ConsumerGamingLos Angeles, US

Alexander Mistakidis(Founder/CEO)inCarter Minshull(Founder/CTO)in

Co-investorsY Combinator

IKAS builds AI and modeling-based industrial intelligent manufacturing solutions for companies across the semiconductor supply chain (chip design, wafer fabrication, packaging and testing, equipment, and materials) as well as the power and energy sector.

Advanced ManufacturingAI & Machine LearningSemiconductorsBeijing, CN

Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials.

AI & Machine LearningBiotechDeep TechMedical DevicesParis, FR

Yann(Co-founder and CEO)Quentin(Co-founder and CSO)Nicolas(Co-founder and CTO)

Co-investorsDebiopharm Innovation FundOmnes Capital

ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Peretz Partensky(Executive Officer, Director)Stuart Alexander Jacobson(Executive Officer, Director)Nina Horowitz(Chief Executive Officer)Rui Tostoes(Chief Technology Officer)Alicia Jackson(Director)

BoardDylan Morris(Director)

Co-investorsNFX

Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.

BiotechDigital HealthMedical DevicesWaltham, US

Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)

BoardLaura Brass(Director)inKai Wucherpfennig(Director)

Co-investorsDC Investment PartnersLongwood FundMedical Excellence CapitalNovartis Venture FundOno Venture Investment, Inc.Solasta Ventures+2 more

iOmx is a clinical-stage biotech company developing targeted cancer immunotherapies for common solid tumor indications, translating tumor immune evasion biology into biomarker-enabled drug programs.

BiotechHealthtech

Co-investorsSofinnova Partners

iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.

BiotechDeep TechHealthtechMedical Devices

Catherine Pickering(Co-Founder & CEO)inLars van der Veen(Co-Founder & CSO)inMichael Lahn(CMO)inElizabeth Holt(CBO)inSteven Sciuto(CFO)inMichelle Tsai(COO)in

Co-investorsInkef3B Future Health FundVI PartnersXGEN Venture

IonKraft, a spin-off from the Institute of Plastics Processing (IKV) at RWTH Aachen University, develops a barrier coating technology for mono-material plastic containers that provides the barrier and chemical resistance of multi-layer packaging while remaining fully recyclable.

Advanced ManufacturingCircular EconomyCleantechNew MaterialsAachen, DE

Bene(Co-Founder & Managing Director)inMonty(Co-Founder & Managing Director)

Co-investorsTechVision Fonds

Kivu Bioscience is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for oncology, using site-specific conjugation technology to create more stable and homogeneous cancer therapies with reduced off-tumor toxicity.

BiotechDeep TechHealthtech

Mohit Trikha(CEO)

Co-investorsBOMHealthCapRed Tree VentureBioGeneration VenturesNovo Holdings

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJames Field(Executive Officer, Director)in

Co-investorsAcequia Capital (AceCap)Air Street CapitalBackedBeast VenturesChampion Hill VenturesGigafund+8 more

LabGenius develops EVA, an automated antibody discovery platform that uses machine learning and automation to identify and co-optimize complex therapeutic antibodies such as multispecifics.

AI & Machine LearningBiotechDeep Tech

Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.

BiotechDeep TechHealthtech

Co-investors+ND CapitalIllumina VenturesLongwall Venture Partners LLPOMX VenturesARCH Venture Partners